We conducted a prospective study ofoffice carbon dioxide (CO) laser turbinoplasty as a treatment for symptoms related toturbinatedysfunctionin58 patients.Allpatients completed surveys before and l month after treatment, and 23 patients completedlonger-term follow-up surveys 8 to 24 months postoperatively. The l-month postoperative assessments demonstrated a trend toward symptom improvement, as many patients reported a decrease in their useofpretreatment medications. Long-term benefit wasachieved in 70% ofpatients. Tenpatients underwent pre-andpost-treatmentbiopsies, and histologic evaluation demonstrated minimal tissue alteration following treatment, alleviatingconcerns ofphysiological andfunctional compromise. We conclude that office-based CO 2 laser turbinoplastyisa usefultoolfor the treatment ofdisorders related toturbinatedysfunction. Wedescribe oneclinician's method ofperforming office CO 2 laser turbinoplasty; and we reporthis experience and findings.
Introduction
The inferior turbinates play an integral role in respiration and nasal physiology.They contribute to inspiratory resistance, the nasal defense system, and mucociliary transport, and they aid in humidification, warming, and cleansing. Pathologic enlargement (hyperplastic inferior turbinates) may lead to a variety of symptoms, including nasal congestion and rhinitis. It may also contribute to increased allergy intensity and exacerbation of sinus disease .
Mucosal inflammation of the inferior turbinates is a common physical finding in patients with allergic rhinitis and vasomotor rhinitis. The medical treatment of these conditions includes the use of nasal steroid sprays , antihistamines, decongestants, ipratropium, saline washes and, in appropriately selected patients with atopic allergy, immunotherapy. However, medical therapy alone is often unsuccessful in alleviating symptoms; in such cases, surgery may be indicated. There are multiple surgical procedures that address hyperplastic inferior turbinates, ranging from minimally invasive procedures (e.g.,laser turbin op lasty,electrocautery, radiofrequen cy ablation, and cryotherapy) to more involved techniques that require general anesthesia (e.g., submucosal resection with a microdebrider, outfracture, and partial or total turbinate resection) . ' The goal of surgery is to alleviate the patient's symptoms while preserving the mucosa and mucociliary function. One possible adverse effect of surgery is atrophic rhinitis, a serious complication of overly aggressive turbinate surgery that results in extensive damage to the mucosa. ' When choosing a technique to decrease turbinate size, clinicians should compare a given technique's efficacy with its risk of compromising function (documented by the presence of short-and long-term side effects). Also, clinicians should factor in the cost to the patient and the provider, including the purchase price of equipment and the reimbursement potential.
Laserturbinoplasty isa minimally invasiveoffice-based procedure that has been shown to be effective in decreasing the size of the turbinates and reducing rhinorrhea. Long-term subjective results are favorable, and one study showed that it was superior to conventional surgical procedures. ' Permanent histopathologic changes in turbinate soft tissue have been demonstrated with preservation of the epithelium .' The goal of our study was to report one clinician's results with office carbon dioxide (CO) laser turbinoplasty and to describe how to perform this procedure effectively and efficiently.
Patients and methods
We prospectively enrolled 85 patients with symptoms related to turbinate dysfunction who presented to the ENT-Ear, Nose & Throat Journal· JUly2008 pr actice of one atte nding otolaryngo logist (G.].S.) between Nov. 1, 2003, and April 30, 2005 . Patients were recru ited on the basis of exhibitingsigns, symp toms,and physical find ings con sistent with tu rbinate pathology. All pati ent s had been treated unsuccessfully with medications prior to study enr ollme nt. Anter ior rhinoscopy and nasal endoscopy were perform ed on all patient s before enrollment. Exclusion crit eria included pre vious turbinate sur gery or septoplasty,severe septal deviation, nasal polyps, chronic rh ino sinusitis, or current allergy immunotherapy.
Pretreatment.AlIpati ents underwent an initial consultation and completed two pretreatment questionnaires. On the first questionnaire, the y were asked to rate the severity of seven symptoms: postnasal drip, nasal congestion/obstruction, rhinorrhea, headache, cough, low energy,and sleep disturbance.Th ey rated each sympto m by indicating whether it sign ificantly, occasionally, or rarel y bothered them. Th ey were also asked about th eir ability to tolerate continuou s positive airw ay pressur e (CPAP) th erapy. On th e secon d qu estionnaire, patients were asked to indicate th e frequency with whi ch the y too k medication s. Th ese medications included nasal steroids, antihistam ines, decon gestants, combination products, and over-the-counter saline sprays.
Patients were instructed to avoid the use of aspirin and ibuprofen for 2 weeks before and 1 week after the pro cedure.
Written informed consent was obtained from all patient s who agreed to participate in the study.Ten patients who agreed to undergo preand pos t-treatment biopsies signed an additiona l consent form for th at purpose. Becau se this study was conducted and completed solely in a pri vate -practice office setting, no Institutional Review Board approval was sought. Nevertheless, appropriate and thorough patient counseling was provided to all patients.
Surgical procedure. Laser turbino plasty was perform ed in an outpatient officesetting by thesenior author (figure) .A Lumenis Encore Sur giTouch/Ult raPul se CO2 laser (Lume n isSur gical;Yokneam, Israel) was used in all cases. Anes thesia was achieved with 4% topical cocain e app lied with nasal pledgets. Laser energy was delivered to the medi al and inferi or surfa cesof the inferior turbinates via handheld 45°nasal probes. Th e laser was set in the SurgiTouch mode at 12 W of continuous energy.Three to five passes of the laser lasting 10 to 20 seconds each were made on each pati ent.
Th e 10 patients who underwent biop sy prior to their procedure and again at th e l -rnonth follow-up did so to Vo lume 87, Number 7
Figure. Laser turbinoplasty can be performed quickly with local anesthesia,
allow for a histopathologic evaluation of the treatment respon se. Samples were taken from the ant eroinferior sur face ofth e left inferior turbinate where the laser beam was applied. Specim ens were immediately embedded in pa raffin, sectioned into 5-llm slices, and placed on glass slides for routine pathologic exam ination and hem atoxylin and eosin staining. Slices were examined with a standard micro scope with a 100x objecti ve and a lox optical lens by one senior pathologist (K.G.H .), who was blinded to any clinical data. Among the histologic data acquired and analyzed were the thickness of the cell linings and basement membranes; the number of intraepithelial eosinophils and polymorphic neutrophils (PMNs); the number of subepithelial eosinophils, PMNs, plasma cells, and mononuclear cells; the number of glandular eosinophils and PMNs, as well as the percent age of glands; and the degree of stromal edema, fibrosi s, vascularity, and myxoid change.
After th e procedure, normal activity was permitted, although patients were cautioned against undergoing strenuous activity. Nasal saline sp ray was advised for th e first week po st-treatment,Ana lgesics and antibiotics were not pr escrib ed.
Follow-up. A tot al of 27 patients dropped out of the study prio r to th e l -rnon th follow-up, leaving us with a final study population of 58 patients-3 1 men aged 24 to 76 years (mean: 48.7) and 27 wom en aged 28 to 78 years (mea n: 48.9).
For the short-term follow-up phase of the study, the 58 patients completed two qu estionnaires 1month after tre atment. On the first que stionnaire, they were asked to rate thei r response to treatment. For each symptom, th ey recorded whether th ey experienced a complete Twopatients experienced a procedure-related complication: epistaxis that required packing.But because both of these patients had undergone turbinate biopsy, we believe that the epistaxis in both cases was the result of the biopsy procedure rather than the laser treatment.
Discussion
The ideal treatment for inferior turbinate pathology would allow the clinician to preserve normal physiology and function while reducing soft-tissue volume. In addition to efficacy, other factors that clinicians should consider when comparing various treatment techniques are patient complianceltolerance, cost, the type of anesthesia (local [outpatient] vs. general), the degree of postoperative pain, and the incidence ofcrusting,bleeding, and side effects. As our knowledge, understanding, and database of information concerning the effects of various treatment techniques on turbinate physiology resolution, a partial response, or no change. On the second questionnaire, they were asked to indicate their need for medication. For each medication that they had been taking prior to treatment, they were asked if their need for it had ceased, decreased, or remained unchanged.
For the long-term follow-up phase of the study, 23 patients continued to complete questionnaires beyond the l-rnonth follow-up.
Results
At the I-month follow-up, there was an overall trend toward resolution ofsymptoms after laserturbinoplasty (table 1) . Also, there was a trend toward a decrease in the need for daily drug therapy, as almost half of the patients (44.4% ) were able to stop their medications altogether (table 2) .
Thirteen of the study patients were CPAP users. Preoperatively, 2 ofthese patients said their nasal symptoms significantly impaired their use of CPAP, 6 reported occasional impairment, and 5 felt that their symptoms rarely impacted their use of CPAP. Postoperatively, no patient complained ofsignificant impairment,4 were occasionally impaired, and 9 were rarely impaired.
In the 10 patients who underwent tissue biopsies, no statistically significant (p < 0.05) pre-and post-treatment histologic difference was seen in any evaluated parameter (table 3) .
Twenty-three patients remained in the study beyond 1 month for longer-term follow-up, which ranged from 8 to 24 months (mean: 15.9). According to their additional questionnaire responses,83% of these patients were pleased with the results of the procedure , 70% were still receiving benefit from it, and 83% continued to require fewer daily Key: Sig= significantly botheredby the symptom preoperatively;Occ = occasionally bothered by the symptom preoperatively; Rare = rarely bothered by the symptom preoperatively.
medications. very precise for cutting and for superficial vaporization of tissue.10 The heat released from the laser results in a thermal coagulation of the surrounding tissue, with a thickness of approximate lyO.5 mm. The precision ofthe CO 2 laser allows the clinician to preserve intact mu cosal islands between treated areas, whic h promotes fast reepithelialization and preserva tion of func tion ." CO 2 laser scan ning electron microscopy has demonstra ted precise ablatio n lines with only small areas of disruption along the bordering respiratory epithelium . The trea ted tissue undergoes no reactive swelling, and the risk of deep coagulatio n to the per iosteum is min imal.10 Venous vessels and sinusoids have been foun d to be and function continue to grow, we will be able to choose the proper treatment met ho d with a greater degree of confidence .
Historically, tur binectomy has been the procedur e of cho ice to effectively relieve nasa l obstruction. However, it is well documented that turbi nectomy often leads to un toward side effects, includi ng dry ness, crusting, bleeding, pain, recurrent feelings of nasal obstruction, and atrophic rhinitis."
Surface electrocautery is a procedure still performed today. Genera lly used in the operating room, it has been shown to be effective in reducing symptoms of nasal tur binate dysfun ction, bu t potentially at the cost of overall nasal function. Surface electrocautery is a destructive process that can lead to tissue necrosis, fibrosis, mucosal atrophy, metaplasia, loss of cilia, and a decrease in mucociliary transport."
Radiofrequency ablation emp loys radiofrequency energy to ablate hypertroph ied nasal turbinates. The radiofrequency catheter is inserted into the submucosa of the hypert rophied inferior turbinate under local anesthesia. The sub mucosal tissue aro und the catheter is heated, and the tissue coagulates. As the lesions heal, the submucosal tissue shrinks. The results of this relatively new procedur e are promising in terms of minimal da mage to surrounding tissue and preservation of mucociliary function." ?
An even newer technique, submucosal resection with a turbinate microdebrider blade, effectively addresses turbinate hypertrophy and allows for the preservation of mucosa, bu t it req uires general anesthesia and longer operating time .'
Lasers function by projecting a beam of coherent light that is absor bed by tissue. The depth of penetration and absorption is dependent on several factors , including laser type, wavelength, app lication mode, and the amount of energy app lied. The CO 2 laser is commonly used for reduci ng hyperplastic turbinates . CO 2 laser energy is absorbed by water, and the laser is destroyed and sealed; thi s is believed to contr ibute to the overall reduction in th e swelling cap abiliti es of the nasal turbinates. Elwany and Abel Salaam performed an in-depth histolo gic an alysis of turbin ate biopsies taken 1 month po st-treatment." Th ey found disor gani zed acini, a decrease in serom ucinous glands, a depletion of secretor y granules, fibrosis of th e connective tissue/stroma, a reduction in th e amount of blo od in the submucosal sinusoids, and a decre ase in vascularity. The resulting alleviation of rhinorrhe a was thought to be the result of changes in th e seromucinous glands, secretory granules, and acin ar cells.
The long-t erm effectiveness of laser surgery was demonstr ated by Wexler et a1. 4 Their study showed histop athologic find ings in which th e epithelium was found to be intact, with near-total elimination of the seromucinous glands and venous sinuso ids.
Obj ective an d subjective evidence of successful result s notwithstanding, opponents of laser sur gery are concerned about its effects on mucociliary function. Some studies have shown a decrease in mucociliary function th at th e investigators concluded may be a sign of irreversible dam age to the nasal m ucosa.Y Subjectively,our study clearly demonstrates th at laser turbinoplasty decreases th e sym ptoms ofpo stn asal dr ip, nasal congestion/obstruction, rhinorr hea,headache,and cough. In addition, many patients described an overall increase in en ergy level po st-treatment . Although th e number of CPAP patient s was small , the study demon strated a trend toward improvem ent in their ability to tolerate CPAP. Laser turbinoplasty app eared to be most effective in thos e patients who demonstr ated th e greatest degre e of sympto ms prior to th e treatment . In addition, pati ent s repor ted a decrease in th e ne ed for daily medications targeted at nasal symptoms.
The histologic data obtain ed from the 10 biopsy specime ns support the belief that laser turbinoplasty does not advers ely effect the submucosal tissue and epithelium . However, given th at we took onl y 10 biopsy specime ns in thi s study, we cannot make an in-depth analysis of th e histologic changes that occur with laser turbinoplasty. Further studies with larger numbers, validated surveys, objecti ve me asures of nasal airflow, and imag ing will be needed before investigators can draw any conclusions regarding chan ges in turbinate function after laser turbinoplasty.
A significant factor to keep in mind when con sidering office laser turbinoplasty is th e cost of th e equ ipment . In fact, purchasing a laser for the sole purpose of 390· www.entjournal.com performing office laser turbinoplasty would not mak e sense financi ally. However, if the physician's practice includes other procedures that can be performed with such equipment-such as facial resurfacing, laserassisted uvulop alatopharyngopl asty, ton sillar ablation, myringotomy, and soft-tissue lesion excision, ablation, and vaporization-the laser can be a solid sour ce of revenue.
In conclusion, office-based CO 2 laser turbinoplasty is a rapid procedure th at is performed with top ical anesth esia. It has a low com plication rate, and it can be used to effectively treat patient s with sym pto ms related to turbinate hypertrophy and dysfunction.The high success rate ,the low morbidity,and the cost-effectiveness of laser turbinoplasty suggest th at it may be a very useful and im portant tool in mo st otolaryngology practices.
